Biopharmaceutical Excipients Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032

Biopharmaceutical Excipients Market Highlights

• Global biopharmaceutical excipients market revenue is poised to garner USD 4.8 billion by 2032 with a CAGR of 7.1% from 2024 to 2032
• North America biopharmaceutical excipients market value occupied around USD 835.2 million in 2023
• Asia-Pacific biopharmaceutical excipients market growth will record a CAGR of more than 8% from 2024 to 2032
• Among product, the carbohydrates sub-segment generated USD 939.6 million revenue in 2023
• Based on end-user, the pharma and biotech companies sub-segment generated significant biopharmaceutical excipients market share in 2023
• Collaborations between excipient makers and biopharmaceutical companies is a popular biopharmaceutical excipients market trend that fuels the industry demand

The steadiness of large molecules is naturally less, when contrasted with little particles. Research and investments made to address the difficulties saw as a consequence of aforementioned fact are relied upon to drive the market in future. Rewarding development of the biopharmaceutical business has made potential opportunity for the conventional drug excipient developers to extend their business activities in this market. Rapid development of the biopharmaceutical business because of expanding manufacturing capacities is one of the key main impetus of biopharmaceutical excipients market. Increase in the quantity of protein therapeutics combined with the presence of a considerable number of excipients to shield these proteins from debasement is additionally driving the market development.

Global Biopharmaceutical Excipients Market Dynamics

Market Drivers

• Increased demand for biologics and biosimilars
• Increasing expenditure in research and development for improved medication formulations
• Chronic diseases are becoming more prevalent, as are aging populations
• Regulatory support for novel excipient development

Market Restraints

• High cost of specialist biopharmaceutical excipients
• The regulatory standards for excipient approval are stringent
• Biopharmaceutical manufacture involves complex processes

Market Opportunities

• Personalized medicine and gene therapies are seeing an increase in demand
• Emerging markets in Asia Pacific and Latin America
• The creation of multifunctional and intelligent excipients

Biopharmaceutical Excipients Market Report Coverage

Biopharmaceutical Excipients Market Insights

Investigational studies about that are executed for the effect examination of excipient variability on in vitro disintegration testing are projected to lessen the attrition rate of definite products and increment the reproducibility. These investigations help researchers in picking up bits of knowledge on the in vivo working and pharmacodynamic examination of extensive atoms. The market displays constant need of inventive excipient advances to drag out the in vivo viability of biologics and for development in the item conveyance. Also, broad R&D for the advancement of crude materials that assistance enhance yields in mammalian cell-culture forms is required to drive the industry in biopharmaceutical excipients market forecast period.

Carbohydrates, especially sucrose, starch, and dextrose drove the market previously and represented the biggest offer in worldwide revenue. Easy accessibility of products at sensible costs has brought about wide use of sucrose as a building and balancing out operator in about 80% of the lyophilized monoclonal counter acting agent based definitions. Also, starch is as a rule customarily utilized in various medication products inferable from its well-defined safety profile. It very well may be changed to grow its properties, which further guides in the detailing of complex delivery systems for large molecules.

Biopharmaceutical Excipients Market Segmentation

The worldwide market for biopharmaceutical excipients is split based on product, end-user, and geography.

Biopharmaceutical Excipients Market By Products

• Solubilizers & Surfactants/Emulsifiers
• Triglycerides
• Esters
• Others
• Polyols
• Mannitol
• Sorbitol
• Others
• Carbohydrates
• Sucrose
• Dextrose
• Starch
• Others
• Specialty Biopharmaceutical Excipients/Others

According to biopharmaceutical excipients industry analysis, carbohydrates, specifically sucrose, dextrose, and starch, provide the most revenue among the product segments. Carbohydrates are commonly utilized as stabilizers, bulking agents, and tonicity modifiers in biopharmaceutical formulations to maintain the stability and efficacy of active pharmaceutical ingredients (APIs) during manufacturing, storage, and administration. Sucrose, for example, is frequently employed in vaccinations and protein-based medications to prevent sensitive components from degrading. Carbohydrates are in great demand due to their wide range of applications in biopharmaceutical products such as injectables, oral formulations, and lyophilized medicines.

Furthermore, their biocompatibility, low toxicity, and well-established safety profiles make them the preferred excipients in the production of complex biologics, resulting in increased market dominance and revenue. As the biopharmaceutical industry grows, the demand for carbohydrate excipients is projected to stay strong.

Biopharmaceutical Excipients Market By End-Users

• Pharma and Biotech Companies
• CMOS and CDMOS
• Academic and Research Institutes

The pharma and biotech companies sector is predicted to make the largest contribution to market growth. These firms are at the forefront of medication development and commercialization, creating a demand for high-quality excipients used in biopharmaceutical formulation, stabilization, and distribution. With the growing emphasis on biologics, vaccines, and sophisticated therapies including gene and cell therapies, the demand for specialized excipients has increased. Pharma and biotech businesses are heavily spending in R&D to create more effective and safer pharmaceuticals, increasing demand for new excipients.

Furthermore, the severe regulatory requirements for biopharmaceuticals mandate the use of high-quality and consistent excipients, which increases reliance on this market. As the global biopharmaceutical sector grows, the Pharma and Biotech Companies category is projected to dominate the market in biopharmaceutical excipients industry forecast period.

Biopharmaceutical Excipients Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of LATAM

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Biopharmaceutical Excipients Market Regional Analysis

In terms of biopharmaceutical excipients market analysis, North America had the largest offer on the global market in 2023, followed by Europe. The presence of improved providers and high research financing in the chemicals division has resulted in an examined offer of these sectors in global revenue. The growth prospects for this industry in these business sectors are expected to be moderate in the future years.

Asia-Pacific is the fastest growing region during the biopharmaceutical excipients industry forecast period. Developing markets, such as India, China, and South Korea, are expected to see positive growth. The anticipated growth in demand for and sales of raw materials in these business sectors can be attributed to the increasing biopharmaceutical industry and the expanding business impression of organizations in Asian countries.

Biopharmaceutical Excipients Market Players

Some of the top biopharmaceutical excipients companies offered in our report includes Clariant, Roquette Frères, Spectrum Chemical Manufacturing Corp., BASF SE, Merck KGaA, Signet Excipients Pvt. Ltd (IMCD), Sigachi Industries Limited, IMCD, Colorcon, and Associated British Foods plc.